When will I start losing weight on semaglutide?

Week one: you probably won't see the scales move yet

Picture this: your pen has arrived, you've given your first injection, and you're wondering whether anything is happening. The honest answer in week one is: probably not much, at least not on the scales. The 0.25 mg starting dose exists to let your digestive system adjust, not to drive weight loss. What you may notice instead is a reduction in appetite (food feels less urgent, portions feel easier to leave) and that shift is exactly what the medicine is designed to produce.

Some people do lose a small amount of weight in the first fortnight, often partly from eating less and partly from fluid changes that follow a change in diet. Don't read too much into a number on day ten. The titration schedule (which a prescriber manages, not you) is deliberately gradual. Most people move from 0.25 mg to 0.5 mg around the four-week mark, and if you're asking when you'll actually start to lose weight on semaglutide, it's typically from that point that things start to become clearer. If you want a fuller picture of what drives semaglutide's effect on weight, the semaglutide overview on our site covers the mechanism in plain language.

One practical note: if your treatment lands just before a bank holiday or you're travelling, the first few weeks of a new medicine are worth planning around, continuity matters more at the start than at any other point.

Weeks four to twelve: where most people start to see consistent loss

The window between one and three months is where a clearer pattern tends to emerge for most people. The dose is increasing, appetite suppression is more sustained, and the cumulative effect of eating less is visible. Semaglutide slows the rate at which the stomach empties, which prolongs the feeling of fullness after meals. It also acts on appetite-regulating centres in the brain via GLP-1 receptor pathways, reducing the pull of food that many people describe as constant before treatment.

Individual variation here is real. Some people lose steadily and consistently from week four; others find progress comes in patches with plateaus between dose increases. Neither pattern signals that the medicine is failing. A plateau around a dose step is common and usually resolves once the new dose is established. The guide to semaglutide and weight loss on this site goes into more detail on what influences the rate of loss and what to do if progress stalls.

If you're thinking about the cost of treatment during this period, our Wegovy pricing page sets out what a private prescription through a regulated UK pharmacy includes, it's worth understanding before you commit to any provider.

Months three to eighteen: where the trial evidence plays out

The most robust data on semaglutide comes from the STEP 1 trial, published in the New England Journal of Medicine. Over 68 weeks, adults using semaglutide 2.4 mg alongside lifestyle support lost an average of around 15% of their body weight, compared with just under 3% in the placebo group. That average conceals a wide spread: some participants lost considerably more, others less.

The implication for your own timeline is straightforward: the strongest results in the trial came from staying on treatment long enough to reach and sustain the maintenance dose. Weight loss tends to continue past month three, often peaking somewhere between months nine and eighteen before levelling. This is why NICE, in its guidance on Wegovy (semaglutide), recommends reviewing whether to continue if less than 5% weight loss has occurred after six months at the maintenance dose, a clinical checkpoint, not an automatic cut-off. If you're specifically on Wegovy and wondering when you should start losing weight on Wegovy, that page sets out what to expect and when to raise concerns with your prescriber. You can read NICE's full recommendation at NICE TA875.

There are also side effects to be aware of, particularly in the earlier weeks. Nausea, loose stools, and indigestion are most common when starting or increasing the dose; they tend to settle as the body adjusts. A small number of people experience more persistent symptoms. If you're curious about a specific concern (such as changes in facial appearance that some patients notice with weight loss medicines) this page addresses that question directly.

What shapes your individual timeline

Semaglutide is not a fixed formula that delivers the same result at the same pace for every person who takes it. Several things influence how quickly weight loss starts and how far it goes. Starting weight matters, a higher body weight often means larger absolute losses, even if the percentage is similar. How closely you reduce calorie intake alongside treatment makes a real difference; the medicine lowers appetite, but food choices still count. Activity level, sleep, stress, and underlying health conditions all play a role too.

Medicines that affect absorption (including some common ones) can interact with semaglutide, and for anyone using oral contraceptives alongside tirzepatide (a related but different medicine), specific precautions apply. These are exactly the kind of individual factors that a prescriber works through with you, which is why the consultation step is clinical rather than a formality. If you're comparing treatment options or considering whether Wegovy is the right choice for your situation, our treatment overview lays out what's licensed in the UK for weight management and how the options differ.

If you'd like a prescriber to review your situation and discuss whether semaglutide is appropriate, you can speak to our prescribers via a free consultation, reviewed the same day by a GPhC-registered clinician, not an automated system.